Interactions between Hepatic Stellate Cells and the Immune System
The DOI matches its Crossref record.
Abstract
Stellate cells and immune cells are both active participants in the pathogenesis of liver disease. Interactions between these two populations are important determinants of disease outcome. Kupffer cells, neutrophils, and lymphocytes all have the potential to influence stellate cells. They produce a host of humoral mediators, including oxidants, nitric oxide, cytokines, eicosanoids, and proteinases, which can affect stellate cell proliferation, gene expression, and contractility. One important feature of stellate cell-immune cell interactions is that they are bidirectional. Not only do stellate cells receive signals from leukocytes, but they also elaborate signals that target leukocytes. Specifically, stellate cells can promote leukocyte chemotaxis and adherence, and they may also influence leukocyte activation by producing regulatory cytokines. Studies in culture provide an important background for understanding the effects of specific mediators on stellate cells and immune cells. Experiments in vivo offer an important adjunct, but often lead to confounding effects that limit interpretation. Both types of studies are required to develop a better understanding of the complex interplay between stellate cells and leukocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interplay between HSCs and hepatic immune cells, long recognized as a key feature of the hepatic injury response, has emerged as an especially important determinant of NASH pathogenesis (5, 7, 8).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [7]
Citations
Cites
Still being checked.
Cited by
Items 201–225 of 225
Milczek, D. V. (2020) · bonndoc (University of Bonn)
The hepatic sinusoid in aging: phenotypic changes and novel therapeutic approaches
Maeso‐Díaz, R. (2020) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Cytokines Involved in the Progression of Liver Fibrosis by Influencing DNA Synthesis
Han, R. (2021) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2021.13.001825
Лукашик, С. П., Tsyrkunov, V. M., Andreev, V. P., Kravchuk, R. I., Abakarova, V. A., Лукашик, С. П., Tsyrkunov, V. M., Andreev, V. P., Kravchuk, R. I., & Abakarova, V. A. (2010) · Epidemiology and Infectious Diseases · doi:10.17816/eid40484
Òdena, G., Stein, E. J., & Bataller, R. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-13614-1_8
Elucidating the effects of interstitial fluid flow on hepatocellular carcinoma invasion
Shah, A., & Shieh, A. C. (2017) · iDEA - Drexel University Institutional Repository · doi:10.17918/etd-7584
Special Lecture: Anti-apoptotic intervention as a novel treatment option in liver diseases
Canbay, A. E., & Gores, G. J. (2007) · Springer eBooks · doi:10.1007/1-4020-5224-3_13
Sinusoidal cells and liver immunology
Szafranska, K., Sørensen, K. K., Lalor, P. F., & McCourt, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95262-0.00003-6
Hepatic Nonparenchymal Cells and Liver-Associated Lymphoid Cells
Gardner, C. R., Laskin, J. D., & Laskin, D. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00250-3
Schwabl, P., Papatheodoridi, Μ., & Pinzani, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-823524-9.00005-8
Sabaté, J. (2012) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Al-Juboori, K. (2024) · DuEPublico (University of Duisburg-Essen) · doi:10.17185/duepublico/82055
Investigation of liver-stellate cell activation and the role of lipolysis in the activation process
Pfleger, R. (2023) · reposiTUm (TU Wien) · doi:10.34726/hss.2023.108046
Charakterisierung der Veto-Funktion von hepatischen Sternzellen
Schildberg, F. (2012) · bonndoc (University of Bonn)
Häberle, L. (2017) · mediaTUM (Technical University of Munich)
Het gebruik van iPSC-afgeleide hepatocytachtige cellen bij hepatotoxiciteitstesten
Ghosh, S. H. (2025) · Lirias
Einfluss der Einzelnukleotidpolymorphismen DDX5 und TRAF1 auf die Leberfibrose
Knipper, A.-S. (2013) · bonndoc (University of Bonn)
Neprilysin und seine Rolle in der Fibrogenese und portalen Hypertension
Reul, W. (2018) · bonndoc (University of Bonn)
Auswirkung von Atorvastatin auf die hepatische Fibrogenese bei gallengangsligierten Ratten
Shir, K. W. (2013) · bonndoc (University of Bonn)
Taroncher, M. (2024) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia)
Influence de la réponse IL-17 dans la physiopathologie du foie
Guillot, A. (2014) · theses.fr (ABES) · doi:10.70675/93867442zef10z413bz8ac0z49dbe1889857
The role of the hepatobiliary-pancreatic system in the pathogenesis of non-rubber alopecies
Lyapunova, N. L., Kashutin, S. L., Иванович, Н. В., Sherstennikova, A. K., & Калмин, О. В. (2025) · University proceedings Volga region Medical sciences · doi:10.21685/2072-3032-2025-4-15
Ramamurthy, R. M., Zheng, W. T., Wachtman, S. E., Diaz, J. H., George, S. K., Simon, T., Zhou, Y., Wan, M., Lu, B., Walker, S. J., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201772
Therapeutics for Alcohol-Associated Liver Disease
Melis, M., Dahshi, H., & Nagy, L. E. (2026) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-060225-121425
Rôle de la cytokine inflammatoire IL-15 dans la progression de la fibrose hépatique
Variya, B. (2019) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
Metadata
- Authors
- Maher, J. J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Maher, Jacquelyn J.
- ORCID
- Maher, Jacquelyn J.
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2001
- Volume
- 21
- Issue
- 03
- Pages
- 417-426
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2087877540
- Cited by
- 198
- References
- 0
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 4 · 2022: 4 · 2021: 7 · 2020: 10 · 2018: 6 · 2017: 8 · 2016: 6 · 2015: 7 · 2014: 8 · 2013: 13 · 2012: 10
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k02aa000215-04, 5r01aa007810-12)
- National Institute on Alcohol Abuse and Alcoholism (AA07810, AA-00215)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK026743)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- hepatic stellate cells, Kupffer cells, neutrophils, lymphocytes, cytokines, nitric oxide, eicosanoids, proteolytic enzymes, stellate cell proliferation, leukocyte chemotaxis, leukocyte activation, liver disease pathogenesis
- MeSH terms
- Cell Adhesion, Cell Communication, Chemotaxis, Humans, Immune System, Kupffer Cells, Leukocytes, Liver, Liver Cirrhosis, Neutrophils, Signal Transduction, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.